Mirion Technologies, Inc. (MIR) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Mirion Technologies, Inc. (MIR) stock forecast summary
On Oct. 14, 2026, MIR is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5379 stocks scored that day.
Mirion Technologies, Inc. is a mid-cap company with a market capitalization of $4.09B. It ranks number 5 by market capitalization among the 9 Measuring & Controlling Devices, NEC issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for MIR is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, MIR included.
Follow MIR freeMIR price chart and AI forecast
How MIR ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Mirion Technologies, Inc. (MIR) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Measuring & Controlling Devices, NEC peers listed below that report each metric.
Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.
Valuation & Market
| Metric | MIR | Rank |
|---|---|---|
| Market Cap | $4.09B | 5/9 |
| P/E Ratio | 166.91x | – |
| P/B Ratio | 2.22x | 7/9 |
| EPS | $0.11 | – |
| Book Value/Share | $7.39 | – |
| Revenue/Share | $4.12 | – |
| FCF/Share | $0.54 | – |
Profitability & Margins
| Metric | MIR | Rank |
|---|---|---|
| ROIC | 1.7% | 5/9 |
| Gross Margin | 48.0% | 6/9 |
| Operating Margin | 6.1% | 6/10 |
| EBT Margin | 3.4% | 5/10 |
| Tax Rate | 15.8% | – |
Financial Health
| Metric | MIR | Rank |
|---|---|---|
| Current Ratio | 3.20x | 3/9 |
| Quick Ratio | 2.63x | 3/9 |
| D/E Ratio | 0.87x | 6/11 |
| Financial Leverage | 1.90x | 6/11 |
| Interest Coverage | 2.5x | 4/9 |
| Working Capital | $619M | 3/9 |
Cash Flow
| Metric | MIR | Rank |
|---|---|---|
| Operating Cash Flow | $173M | 5/10 |
| Free Cash Flow | $134M | 4/8 |
| Capital Spending | -$39M | 6/8 |
| OCF Growth YoY | 37.2% | 3/5 |
| FCF Growth YoY | 59.7% | – |
| FCF/Sales | 13.1% | 4/8 |
| CapEx/Sales | 3.8% | 3/8 |
Operational Efficiency
| Metric | MIR | Rank |
|---|---|---|
| Asset Turnover | 0.29x | 7/8 |
| Receivables Turnover | 5.8x | 5/8 |
| Inventory Turnover | 3.3x | 3/8 |
| Fixed Assets Turnover | 6.6x | 5/8 |
| Days Sales Outstanding | 63 days | 4/8 |
| Days Inventory | 109 days | 6/8 |
| Payables Period | 41 days | 7/8 |
| Cash Conversion Cycle | 131 days | 4/7 |
Income Statement
| Metric | MIR | Rank |
|---|---|---|
| Total Revenue | $1.02B | 4/8 |
| Operating Income | $54M | 5/10 |
| R&D Expense | $40M | 6/10 |
| SG&A Expense | $398M | 4/10 |
| Cost of Goods Sold | $533M | 4/9 |
Dividend & Shareholder Information
| Metric | MIR | Rank |
|---|---|---|
| Shares Outstanding | 249M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $900M | 25.8% of assets |
| Cash & Short-term Investments | $419M | 12.0% of assets |
| Accounts Receivable | $177M | 5.1% of assets |
| Inventory | $159M | 4.6% of assets |
| Total Liabilities | $1.60B | 45.9% of assets |
| Short-term Debt | $221M | 6.3% of assets |
MIR quarterly financials and insider trading
Mirion Technologies, Inc. (MIR) industry peers
Companies classified under the same SEC industry code as Mirion Technologies, Inc. (Measuring & Controlling Devices, NEC): 11 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| MIR Mirion Technologies, Inc. | ▶ | $4.09B |
| TMO Thermo Fisher Scientific Inc. | ▼ | $244.86B |
| ROK Rockwell Automation, Inc | ▼ | $48.19B |
| TRMB Trimble Inc. | ▼ | $13.87B |
| ONTO Onto Innovation Inc. | ▶ | $13.43B |
| OWLT Owlet, Inc. | ▶ | $135M |
| GEOS Geospace Technologies Corp | ▲ | $61M |
| BCHT Birchtech Corp. | ▶ | $37M |
| NIKI Niki Biosolutions, Inc. | ▼ | $2M |
| AATC Autoscope Technologies Corp | ▶ | N/A |
| QSI Quantum-Si Inc | ▶ | N/A |
Where MIR sits on the market map
Mirion Technologies, Inc. (MIR) stock news
Loading...
Mirion Technologies, Inc. (MIR) stock forecast FAQ
What is the Mirion Technologies, Inc. (MIR) stock forecast?
On Oct. 14, 2026, MIR is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5379 stocks scored that day.
How accurate are Mirion Technologies, Inc. stock predictions?
A per-ticker accuracy statistic for MIR is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Mirion Technologies, Inc. forecasts updated?
Mirion Technologies, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Mirion Technologies, Inc.'s industry peers?
11 issuers in our coverage, MIR included, share the SEC industry code Measuring & Controlling Devices, NEC. The largest are: Thermo Fisher Scientific Inc. (TMO), Rockwell Automation, Inc (ROK), Trimble Inc. (TRMB), Onto Innovation Inc. (ONTO), Owlet, Inc. (OWLT), Geospace Technologies Corp (GEOS).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.